Brief: Interpace Diagnostics Says New York State Approves Commercialization Of Thyramir Now In Three Specimens

Interpace Biosciences

23/04/2019 12:11

April 23 (Reuters) - Interpace Diagnostics Group Inc
 IDXG.O :
    * INTERPACE DIAGNOSTICS GROUP INC - STATE OF NEW YORK
APPROVES
COMMERCIALIZATION OF THYRAMIR NOW IN THREE SPECIMENS

Source text for Eikon:  ID:nGNX3W55jR 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))